Notice: This company has been marked as potentially delisted and may not be actively trading. GTX (GTXI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends GTXI vs. FBIO, DOMH, CRIS, BOLT, SABS, MTEM, AMGN, GILD, VRTX, and REGNShould you be buying GTX stock or one of its competitors? The main competitors of GTX include Fortress Biotech (FBIO), Dominari (DOMH), Curis (CRIS), Bolt Biotherapeutics (BOLT), SAB Biotherapeutics (SABS), Molecular Templates (MTEM), Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and Regeneron Pharmaceuticals (REGN). These companies are all part of the "biotechnology" industry. GTX vs. Fortress Biotech Dominari Curis Bolt Biotherapeutics SAB Biotherapeutics Molecular Templates Amgen Gilead Sciences Vertex Pharmaceuticals Regeneron Pharmaceuticals Fortress Biotech (NASDAQ:FBIO) and GTX (NASDAQ:GTXI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, community ranking, institutional ownership and profitability. Do insiders & institutionals believe in FBIO or GTXI? 96.5% of Fortress Biotech shares are held by institutional investors. Comparatively, 9.5% of GTX shares are held by institutional investors. 33.4% of Fortress Biotech shares are held by company insiders. Comparatively, 40.9% of GTX shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer FBIO or GTXI? Fortress Biotech received 13 more outperform votes than GTX when rated by MarketBeat users. However, 73.60% of users gave GTX an outperform vote while only 63.69% of users gave Fortress Biotech an outperform vote. CompanyUnderperformOutperformFortress BiotechOutperform Votes32863.69% Underperform Votes18736.31% GTXOutperform Votes31573.60% Underperform Votes11326.40% Is FBIO or GTXI more profitable? GTX has a net margin of 0.00% compared to Fortress Biotech's net margin of -84.53%. Fortress Biotech's return on equity of 0.00% beat GTX's return on equity.Company Net Margins Return on Equity Return on Assets Fortress Biotech-84.53% N/A -34.93% GTX N/A -104.19%-86.42% Does the media favor FBIO or GTXI? In the previous week, Fortress Biotech had 10 more articles in the media than GTX. MarketBeat recorded 10 mentions for Fortress Biotech and 0 mentions for GTX. Fortress Biotech's average media sentiment score of 0.34 beat GTX's score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the media. Company Overall Sentiment Fortress Biotech Neutral GTX Neutral Which has more risk and volatility, FBIO or GTXI? Fortress Biotech has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Comparatively, GTX has a beta of 2.22, indicating that its share price is 122% more volatile than the S&P 500. Which has higher valuation and earnings, FBIO or GTXI? GTX has lower revenue, but higher earnings than Fortress Biotech. Fortress Biotech is trading at a lower price-to-earnings ratio than GTX, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFortress Biotech$62.50M0.76-$60.64M-$3.05-0.57GTXN/AN/A-$38.42M-$1.65-0.32 Do analysts rate FBIO or GTXI? Fortress Biotech presently has a consensus target price of $15.67, indicating a potential upside of 805.59%. Given Fortress Biotech's stronger consensus rating and higher probable upside, equities research analysts clearly believe Fortress Biotech is more favorable than GTX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fortress Biotech 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00GTX 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryFortress Biotech beats GTX on 10 of the 17 factors compared between the two stocks. Remove Ads Get GTX News Delivered to You Automatically Sign up to receive the latest news and ratings for GTXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GTXI vs. The Competition Export to ExcelMetricGTXPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.67M$6.93B$5.64B$8.08BDividend YieldN/A2.71%4.89%4.04%P/E Ratio-0.326.1223.7319.00Price / SalesN/A226.08381.75120.61Price / CashN/A65.6738.0534.64Price / Book0.486.656.904.26Net Income-$38.42M$139.34M$3.18B$247.00M GTX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GTXIGTXN/A$0.53flatN/AN/A$12.67MN/A-0.3221FBIOFortress Biotech2.6173 of 5 stars$1.52-3.2%$13.67+799.1%-13.5%$43.34M$62.50M-0.50170Analyst ForecastAnalyst RevisionNews CoverageGap UpDOMHDominari2.048 of 5 stars$6.55-16.0%N/A+165.2%$41.50M$12.59M-1.694Short Interest ↓CRISCuris3.2605 of 5 stars$2.93-2.3%$23.00+685.0%-74.3%$24.81M$10.26M-0.3860Upcoming EarningsPositive NewsGap UpBOLTBolt Biotherapeutics3.7408 of 5 stars$0.44-6.9%$3.50+692.4%-66.7%$16.91M$9.78M-0.2690Short Interest ↓Positive NewsGap UpSABSSAB Biotherapeutics3.173 of 5 stars$1.56-8.8%$12.40+694.9%-72.3%$14.40M$2.24M0.00140Short Interest ↑MTEMMolecular Templates1.0557 of 5 stars$0.00flatN/A-100.0%$3,000.00$23.48M0.00260AMGNAmgen4.0388 of 5 stars$310.78+0.9%$314.09+1.1%+15.8%$165.49B$33.42B41.1628,000Analyst RevisionPositive NewsGap DownGILDGilead Sciences4.4135 of 5 stars$115.99+1.5%$102.08-12.0%+51.9%$144.55B$28.75B313.4918,000Analyst ForecastInsider TradePositive NewsVRTXVertex Pharmaceuticals3.8214 of 5 stars$483.31+0.7%$506.70+4.8%+17.8%$124.11B$11.02B-219.696,100Analyst UpgradeInsider TradePositive NewsREGNRegeneron Pharmaceuticals4.669 of 5 stars$684.87-2.0%$973.13+42.1%-25.5%$74.87B$14.20B17.8915,106Short Interest ↑ Remove Ads Related Companies and Tools Related Companies Fortress Biotech Competitors Dominari Competitors Curis Competitors Bolt Biotherapeutics Competitors SAB Biotherapeutics Competitors Molecular Templates Competitors Amgen Competitors Gilead Sciences Competitors Vertex Pharmaceuticals Competitors Regeneron Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GTXI) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | SponsoredMagnificent 7 wipeout: What's next?A massive wave of volatility is sweeping the stock market... After the recent selloff, the "Magnificent Sev...Chaikin Analytics | SponsoredWarren Buffet Just Made a $334 Billion BetDebt is out of control. Inflation is creeping back. And a major market downturn could be right around the corn...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GTx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GTX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GTXI Stock Alerts